loader2
Login Open ICICI 3-in-1 Account

Jan 19, 2026

loader2

Open ICICI 3-in-1 Account

Manage your Savings, Demat and Trading Account conveniently at one place

What is Nifty 200?

Company Name PE Mcap/Sales P/BV EV/EBIDTA D/E ROCE ROE
Abbott India Ltd 39.12 9.16 14.70 38.08 0.04 44.95 35.66
Cipla Ltd 20.78 4.10 3.43 16.13 0.02 23.15 18.28
J B Chemicals & Pharmaceuticals Ltd 41.46 7.60 7.84 29.61 0.06 26.42 20.75
Dr Reddys Laboratories Ltd 17.10 3.01 2.72 12.09 0.11 23.05 18.53
Lupin Ltd 22.87 4.38 5.07 19.20 0.27 20.88 21.00
Torrent Pharmaceuticals Ltd 63.56 11.81 16.10 42.27 0.50 25.84 26.46
Ipca Laboratories Ltd 44.84 4.28 5.16 26.14 0.21 17.12 13.61
Sun Pharmaceutical Industries Ltd 38.20 7.62 5.15 25.92 0.04 19.52 16.16
Aurobindo Pharma Ltd 19.90 2.15 1.94 11.22 0.24 14.16 11.15
Wockhardt Ltd -455.16 7.71 5.08 81.76 0.57 3.87 -1.48
Ajanta Pharma Ltd 34.39 7.20 7.76 26.12 0.01 31.98 25.02
Gland Pharma Ltd 35.53 5.00 2.94 18.72 0.00 15.83 11.62
Biocon Ltd 74.61 3.73 1.69 20.89 0.84 6.86 6.90
Alkem Laboratories Ltd 28.95 5.38 5.23 28.48 0.13 20.03 19.88
Glenmark Pharmaceuticals Ltd 55.91 4.24 5.89 31.88 0.22 18.48 15.79
Zydus Lifesciences Ltd 17.36 3.76 3.45 12.04 0.09 24.56 21.08
Divis Laboratories Ltd 66.59 17.68 10.74 54.92 0.00 20.42 15.35
Mankind Pharma Ltd 50.64 7.36 5.87 33.44 0.37 16.04 14.83
Laurus Labs Ltd 85.22 10.46 12.10 59.19 0.62 8.80 7.36
Piramal Pharma Ltd -924.17 2.42 2.74 22.23 0.60 6.43 1.14

Other Indices

INDEX NAME MARKET VALUE 52W HIGH 52W LOW
Nifty Next 50 68740.70
(-0.1702%)
70833.65 56192.45
Nifty Bank 59875.05
(-0.3663%)
60437.35 47702.90
Nifty 50 25556.25
(-0.5375%)
26373.20 21743.65
Nifty 100 26158.50
(-0.4824%)
26975.15 22177.35
BSE SmallCap 49122.90
(-1.1650%)
55792.26 41013.68
BSE Sensex 83099.88
(-0.5630%)
86159.02 71425.01
BSE MidCap 45968.95
(-0.4701%)
47764.30 37203.21
BSE 100 26818.78
(-0.5191%)
27621.72 22539.11

Nifty Pharma

The NIFTY Pharma Index reflects the behaviour and performance of the pharmaceutical sector in India. The index has a maximum of 20 stocks since the last amendment effective from 30th September 2021. The NIFTY Pharma stocks are calculated using the free-float market capitalization method and can be used for benchmarking fund portfolios, among other utilization for investors. The index was launched in July 2005; the base date being 1st January 2001 with a base value of 1000. Index is re-balanced on semi-annual basis. The cut-off date is January 31 and July 31 of each year. When rebalancing, the weightage of each stock in the index is calculated such that no single stock has a weightage of more than 33%, and that of top 3 stocks cumulatively shall not be more than 62%.

News

SEBI changes closing price calculation methodology for equity cash segment

In a recently released circular, the Securities and Exchange Board of India (SEBI) said that the clo...

Jan 17, 2026 12:16
Embassy Office Parks REIT fixes record date for distribution

Embassy Office Parks REIT has fixed 11 February 2026 as record date for payment of distribution to unitho...

Jan 16, 2026 19:27
BSE rolls out four new midcap factor indices

BSE Index Services launched four new factor indices based on the BSE 150 Midcap Index, adding to its rang...

Jan 16, 2026 10:36
Angel One fixes record date for interim dividend

Angel One has fixed 21 January 2026 as record date for first interim dividend of Rs 23 per share for FY 2...

Jan 16, 2026 08:59
Zensar Technologies fixes record date for interim dividend

Zensar Technologies has fixed 29 January 2026 as record date for interim dividend, if declared.P...

Jan 16, 2026 08:57
Insecticides India fixes record date for interim dividend

Insecticides India has fixed 06 February 2026 as record date for payment of interim dividend for FY26, i...

Jan 15, 2026 13:09
Disclaimer

ICICI Securities Ltd. Registered office of ICICI Securities is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Mumbai - 400025, India, Tel No:- 022 - 2288 2460, 022 - 2288 2470. ICICI Securities is a Member of National Stock Exchange of India Ltd (Member Code:-07730) and BSE Ltd (Member Code :103) and having SEBI registration no. INZ000183631. SEBI research analyst Registration no.-INH000000990. Name of the Compliance officer (broking): Mr. Anoop Goyal, Contact number: 022-40701000, E-mail address: complianceofficer@icicisecurities.com. Investment in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest.  ICICI Securities and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. The non-broking products / services like Mutual Funds, Insurance, FD/ Bonds, loans, PMS, Tax, Elocker, NPS, IPO, Research, Financial Learning etc. are not exchange traded products / services and ICICI Securities Ltd. is just acting as a distributor/ referral Agent of such products / services and all disputes with respect to the distribution activity would not have access to Exchange investor redressal or Arbitration mechanism.